<?xml version="1.0" encoding="UTF-8"?>
<Label drug="loprox1" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  In the controlled clinical trial with 89 patients using LOPROX  (r)  Topical Suspension and 89 patients using the vehicle, the incidence of adverse reactions was low. Those considered possibly related to treatment or occurring in more than one patient were pruritus, which occurred in two patients using ciclopirox suspension and one patient using the suspension vehicle, and burning, which occurred in one patient using ciclopirox suspension.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
